Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials
...Targeting Drug-resistant Bacteria Investment to accelerate development of a novel class of targeted high-potency bacteriocins against...
top of page
press releases
bottom of page